title: Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
authors.affiliation: From University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (D.A.L.); Duke University School of Nursing, Durham, NC (K.W.). deirdrelane@nhs.net d.a.lane@bham.ac.uk.
authors.forename: Deirdre A
authors.initials: DA
authors.lastname: Lane
authors.affiliation: From University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (D.A.L.); Duke University School of Nursing, Durham, NC (K.W.).
authors.forename: Kathryn
authors.initials: K
authors.lastname: Wood
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D000069604:Dabigatran; D004347:Drug Interactions; D016903:Drug Monitoring; D057915:Drug Substitution; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D007677:Kidney Function Tests; D008297:Male; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D000069552:Rivaroxaban; D020521:Stroke / Q000517:prevention & control*; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013844:Thiazoles; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran; C552171:edoxaban